FilingReader Intelligence
Alkem Laboratories reports strong Q1 growth across markets
August 19, 2025 at 05:19 AM UTC•By FilingReader AI
Alkem Laboratories reported revenue of INR33,711 million for Q1 FY26, up 11.2% year-on-year. India sales grew 12% to INR22,656 million, while US business increased 8.8% to INR6,982 million.
EBITDA jumped 21.4% to INR7,391 million with margins of 21.9%. Net profit rose 21.8% to INR6,643 million.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:ALKEM•Bombay Stock Exchange
News Alerts
Get instant email alerts when Alkem Laboratories publishes news
Free account required • Unsubscribe anytime